Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07094256 · ClinicalTrials.gov registry record · NA
Torque Device Evaluation
A NA study of Ablation and Electrophysiology Study, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT07094256 is a NA study of Ablation and Electrophysiology Study that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 25 participants, below the 101-participant average among 4 other Ablation trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07094256, a NA study of Ablation and Electrophysiology Study, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate the safety and efficacy of a novel catheter torque device after the completion of a clinically-indicated electrophysiology study and/or ablation procedure in a pediatric patient. All electrophysiology studies and/or ablation procedures will be performed at the discretion of their primary cardiologist and will not be affected by this study protocol. The study protocol will commence once the attending electrophysiologist has completed all necessary intervention and testing and no further evaluation is required.
Conditions Studied
Interventions
- DEVICE Peritorq
Study Locations (2)
District of Columbia
- Children's National - Washington D.C.
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2026-08-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07094256
The ClinicalTrials.gov registry entry for NCT07094256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 4 other Ablation trials with a reported enrollment target (75% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ablation appearing as the primary indexed condition, and to 1 intervention - of which Peritorq is the first listed.
NCT07094256 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07094256 about?
NCT07094256 is a clinical study titled "Torque Device Evaluation". This study will evaluate the safety and efficacy of a novel catheter torque device after the completion of a clinically-indicated electrophysiology study and/or ablation procedure in a pediatric patient. All electrophysiology studies and/or ablation procedures will be performed at the discretion of ...
What is the current status of trial NCT07094256?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-08-25. Estimated completion is 2026-08-04.
What conditions does trial NCT07094256 study?
This clinical trial studies the following conditions: Ablation, Electrophysiology Study.
What interventions are being tested in trial NCT07094256?
The interventions under investigation include: Peritorq (DEVICE).
Who is sponsoring clinical trial NCT07094256?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07094256 being conducted?
This trial has 2 study locations across District of Columbia, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ablation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
RECRUITING · NA
-
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
RECRUITING · NA
-
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.